Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Endothelial Progenitor Cells Dysregulation and Inflammation in the Pathophysiology of Cardiovascular Complications of Type 2 Diabetes

NCT07556497 is registered in ClinicalTrials.gov with Weill Cornell Medical College in Qatar as lead sponsor.

NCT NCT07556497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07556497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Endothelial Progenitor Cells Dysregulation and Inflammation in the Pathophysiology of Cardiovascular Complications of Type 2 Diabetes
Lead sponsor
Weill Cornell Medical College in Qatar
Phase
Observational
Overall status
Recruiting
Start date
November 17, 2020
Completion date
December 31, 2026
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardio vascular disease, diabete type 2